LANGER DENNIS 4 SEC Filings

Filed On	Filing
28 Aug 2026	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Received 34,534 shares as a grant or award ($178K)
06 Feb 2026	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Granted 21,709 Share Option (Right to Buy)
15 Oct 2025	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Bought 15,152 shares ($129K) · Acquired 15,152 Series H Warrants (Right to Buy) (Open Market Purchase) · Acquired 15,152 Series I Warrants (Right to Buy) (Open Market Purchase) · 2 more
25 Aug 2025	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Granted 13,682 Share Option (Right to Buy)
02 Jun 2025	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Granted 7,760 Share Option (Right to Buy)
10 Dec 2024	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Granted 50,714 Share Option (Right to Buy)
10 Jun 2024	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Sold 297 shares ($217)
30 Oct 2023	Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd Granted 7,652 Share Option (Right to Buy)
30 Jun 2022	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Holds 106,802 shares of Common Stock
03 Jun 2022	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 17,275 shares as a grant or award
10 Dec 2021	Form 4: Langer Dennis, Director · Ernexa Therapeutics Inc Granted 67,000 Stock Option
05 Aug 2021	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 30,000 shares by exercise or conversion ($762K) · Sold 30,000 shares ($1.04M)
04 Jun 2021	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 12,848 shares as a grant or award
07 Dec 2020	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 15,889 shares as a grant or award
06 Dec 2019	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 11,687 shares as a grant or award
21 Jun 2019	Form 4: Langer Dennis, Director · Dicerna Pharmaceuticals Inc Granted 25,000 Director Stock Option (right to buy)
30 Nov 2018	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 9,360 shares as a grant or award
17 Aug 2018	Form 4: Langer Dennis, Director · Dicerna Pharmaceuticals Inc Sold 38,341 shares ($613K)
25 Jun 2018	Form 4: Langer Dennis, Director · Dicerna Pharmaceuticals Inc Granted 25,000 Director Stock Option (right to buy)
08 Jun 2018	Form 4: Langer Dennis, Director · Myriad Genetics, Inc. Received 3,609 shares by exercise or conversion ($76.8K) · Sold 3,609 shares ($142K) · Received 3,096 shares by exercise or conversion ($65.9K) · 3 more

Comments